1. Effects of omalizumab in Aspergillus-associated airway disease. Issue 6 (11th March 2011) Authors: Pérez-de-Llano, L A; Vennera, M C; Parra, A; Guallar, J; Marin, M; Asensio, O; Ausin, P; Borderías, L; Fernández, C; Granel, C; Pérez-Pimiento, A; Rubio, M Journal: Thorax Issue: Volume 66:Issue 6(2011) Page Start: 539 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. PKP-027 Significant interactions in treatment of dravet syndrome. (14th February 2016) Authors: Idoate, AI; Aldaz, A; Parra, A; Sanchez-Carpintero, R Journal: European journal of hospital pharmacy Issue: Volume 23(2016)Supplement 1 Page Start: A190 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. PS-068 Utility of root cause analysis to improve safety in the use of iodinated contrast agents. (24th March 2015) Authors: Gómez de Travecedo, MT; Almendral, A; Gavira, R; Vargas, J; Reinado, M; De Tena, S; Parra, A; Fernandez, M; Gómez, F; Gázquez, R Journal: European journal of hospital pharmacy Issue: Volume 22(2015)Supplement 1 Page Start: A163 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗